3-phenylmethanesulfonyl-propionic acid amide | 112982-07-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-phenylmethanesulfonyl-propionic acid amide
• 英文别名: 3-Phenylmethansulfonyl-propionsaeure-amid；3-Benzylsulfon-propionsaeure-amid；3-Benzylsulfon-propionamid；3-(Benzylsulfonyl)propanamide；3-benzylsulfonylpropanamide
• CAS: 112982-07-7
• 化学式: C₁₀H₁₃NO₃S
• mdl: MFCD00025536
• 分子量: 227.284
• InChiKey: BMBCBBLMHJNKQR-UHFFFAOYSA-N

物化性质

• 沸点：
  540.7±43.0 °C(Predicted)
• 密度：
  1.283±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  85.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-(benzylsulfonyl)propanenitrile 在 硫酸 作用下， 生成 3-phenylmethanesulfonyl-propionic acid amide
  参考文献：
  名称：

  Reactions of Mercaptans with Acrylic and Methacrylic Derivatives

  摘要：

  DOI：

  10.1021/ja01202a024

文献信息

• [EN] PEPTIDIC COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS<br/>[FR] COMPOSES PEPTIDIQUES EN TANT QU'INHIBITEURS DE LA PROTEASE A CYSTEINE
  申请人：AXYS PHARM INC

  公开号：WO2004000838A1

  公开（公告）日：2003-12-31

  The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

  本发明涉及一种抑制半胱氨酸蛋白酶的化合物，特别是卡特普辛B、K、L、F和S，因此在治疗由这些蛋白酶介导的疾病方面具有用途。本发明涉及包含这些化合物的药物组合物以及制备它们的方法。
• EL-FETOOH, ABOU;HAMMAM, G.;SANAA, O.;ALLAH, ABD, EGYPT. J. CHEM., 28,(1985) N 2, 153-162
  作者：EL-FETOOH, ABOU、HAMMAM, G.、SANAA, O.、ALLAH, ABD

  DOI：——

  日期：——
• CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS
  申请人：AXYS PHARMACEUTICALS, INC.

  公开号：EP1397340A2

  公开（公告）日：2004-03-17
• USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC
  申请人：AXYS PHARMACEUTICALS, INC.

  公开号：EP1694357A1

  公开（公告）日：2006-08-30
• [EN] NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS<br/>[FR] NOUVEAUX COMPOSES ET COMPOSITIONS UTILISES EN TANT QU'INHIBITEURS DE CATHEPSINE
  申请人：AXYS PHARM INC

  公开号：WO2002098850A2

  公开（公告）日：2002-12-12

  The present invention relates to coumponds of formula (I) (in which X1 is-NHC(R1)(R2)X3 or -NHX4 and the other variables are as defined in the claims) and the pharmaceutically acceptable salts and N-oxides therof, useful as selective cathepsin S inhibitors, their uses as therapeutic agents and the methods for their making. Formula (I):